PA
SPPI

Profund Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Profund Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,458
Closed -$21K – 1436
2021
Q4 		$21K Sell
16,458
-10,554
-39% -$18.9K ﹤0.01% 1370
2021
Q3 		$59K Sell
27,012
-4,231
-14% -$11.6K ﹤0.01% 1338
2021
Q2 		$117K Buy
31,243
+4,794
+18% +$16.7K ﹤0.01% 1399
2021
Q1 		$86K Buy
26,449
+622
+2% +$2.23K ﹤0.01% 1331
2020
Q4 		$88K Buy
25,827
+4,835
+23% +$19.9K ﹤0.01% 1174
2020
Q3 		$86K Buy
20,992
+3,275
+18% +$12.5K ﹤0.01% 945
2020
Q2 		$60K Buy
17,717
+2,584
+17% +$7.53K ﹤0.01% 926
2020
Q1 		$35K Sell
15,133
-4,122
-21% -$11.3K ﹤0.01% 742
2019
Q4 		$70K Buy
19,255
+1,194
+7% +$9.65K ﹤0.01% 1248
2019
Q3 		$150K Sell
18,061
-384
-2% -$3.11K 0.01% 1214
2019
Q2 		$159K Sell
18,445
-935
-5% -$8.36K 0.01% 1161
2019
Q1 		$207K Sell
19,380
-12,021
-38% -$129K 0.01% 1119
2018
Q4 		$275K Sell
31,401
-4,968
-14% -$63.3K 0.02% 811
2018
Q3 		$611K Buy
36,369
+16,721
+85% +$362K 0.02% 646
2018
Q2 		$412K Buy
19,648
+2,055
+12% +$38.1K 0.02% 931
2018
Q1 		$283K Buy
17,593
+3,610
+26% +$71.5K 0.01% 1188
2017
Q4 		$265K Sell
13,983
-47
-0.3% -$851 0.01% 1210
2017
Q3 		$197K Buy
14,030
+2,577
+23% +$23.3K 0.01% 1351
2017
Q2 		$85K Sell
11,453
-4,299
-27% -$28.1K ﹤0.01% 1408
2017
Q1 		$102K Sell
15,752
-6,380
-29% -$35.7K ﹤0.01% 1441
2016
Q4 		$98K Buy
22,132
+8,456
+62% +$35.5K ﹤0.01% 1526
2016
Q3 		$64K Sell
13,676
-2,705
-17% -$16K ﹤0.01% 1410
2016
Q2 		$108K Buy
16,381
+817
+5% +$5.77K 0.01% 1425
2016
Q1 		$99K Buy
+15,564
New +$79.9K 0.01% 1418
2015
Q3 		– Sell
-11,930
Closed -$82K – 1391
2015
Q2 		$82K Sell
11,930
-1,700
-12% -$10.8K ﹤0.01% 1448
2015
Q1 		$83K Buy
+13,630
New +$90.7K ﹤0.01% 1506
2014
Q3 		– Sell
-15,411
Closed -$125K – 1468
2014
Q2 		$125K Sell
15,411
-387
-2% -$2.94K 0.01% 1481
2014
Q1 		$124K Sell
15,798
-3,024
-16% -$25.6K 0.01% 1505
2013
Q4 		$167K Buy
18,822
+4,744
+34% +$42.4K 0.01% 1618
2013
Q3 		$118K Buy
14,078
+2,422
+21% +$19.6K 0.01% 1602
2013
Q2 		$87K Buy
+11,656
New +$89.4K 0.01% 1351

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Profund Advisors's SPPI Position: Q1 2022 in Review

Profund Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 16,458 shares — an estimated $21K sold.

Profund Advisors first reported a position in SPPI in Q2 2013 and held it in 31 quarters. The position peaked at $611K in Q3 2018. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Profund Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Profund Advisors sold 16,458 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $21K.
  • Profund Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
  • Profund Advisors's Spectrum Pharmaceuticals Inc position peaked at $611K in Q3 2018.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Profund Advisors's 13F filing for Q1 2022, filed 10 May 2022.